George Gauthier, Chief Commercial Officer at IGM Biosciences, Inc. (IGMS), sold 935 shares at $7.95 ($7K) on 2023-10-02, disclosed to the SEC on 2023-10-03.
Scheduled sale ($7k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IGMS | SELL | 2023-05-25 | $15K | — | Filing → |
| IGMS | SELL | 2023-04-06 | $12K | — | Filing → |
| IGMS | SELL | 2023-03-16 | $20K | — | Filing → |